Felicis

felicis.com ↗Activity from announced rounds

Activity in this selectionJun 30, 2026 · Jun 1, 2026

Felicis primarily invests at seed and Series A, often leading or co-leading rounds, across AI, cybersecurity, defence, energy, resilience and healthcare technology.

The firm allocates 1% of each initial investment to founder support, including coaching and personal development. This is a specific budget for the founder’s ability to lead as the organisation grows.

Felicis also makes a public commitment to vote with founders. Its combination of early lead investing and founder development is relevant to entrepreneurs choosing a first institutional partner who will influence both financing and board decisions.

Sources
Rounds participated in
4
Confirmed lead rounds
—
4 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$750M
4 disclosed · full round size, not this investor’s share

By stage

Series C+2
Seed1
Series A1

By primary sector

Cybersecurity1
Developer tools1
Enterprise software1
Healthtech1

By country

United States4

Rounds

4 in this selection
Runlayer

Provides an AI enablement and governance platform giving enterprises secure control over AI agents

$30MSeries A
Role not disclosed
Assort Health

Provides AI-powered patient journey platform for healthcare organizations

$120MSeries C
Role not disclosed
Ent

Provides intent-aware workspace security platform that prevents AI-era threats across human and AI agent actions

$100MSeed
Role not disclosed
Supabase

Provides an open source Postgres platform with databases, authentication, storage and application backend services.

$500MSeries F
Role not disclosed